Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,140 Cr
up ₹735 Cr vs Jun 2024
- Stocks held
- 32
- up 1 vs Jun 2024
- Top 10 weight
- 60.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 3
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In July 2024 it disclosed 32 stocks worth ₹8,140 Cr, up ₹735 Cr from Jun 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Divi's Laboratories Limited (8.2%), Lupin Limited (7.5%); the ten largest together made up 60.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.2% of its equity. Cash and debt stood at 1.5%. Compared with Jun 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
24%
Holds more cash than 24% of peers
Holdings in July 2024
Download CSVEvery line the fund disclosed, with the change against Jun 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.85%
- Δ weight
- up 0.38 pts
- Value
- ₹1,127 Cr
- Δ value
- up ₹130 Cr
- Status
- Added
- Weight
- 8.17%
- Δ weight
- down 0.22 pts
- Value
- ₹665 Cr
- Δ value
- up ₹44.1 Cr
- Status
- Added
- Weight
- 7.52%
- Δ weight
- down 0.15 pts
- Value
- ₹612 Cr
- Δ value
- up ₹44.4 Cr
- Status
- Added
- Weight
- 5.88%
- Δ weight
- down 0.32 pts
- Value
- ₹479 Cr
- Δ value
- up ₹19.7 Cr
- Status
- Added
- Weight
- 5.81%
- Δ weight
- down 0.25 pts
- Value
- ₹473 Cr
- Δ value
- up ₹24.4 Cr
- Status
- Added
- Weight
- 5.27%
- Δ weight
- down 0.15 pts
- Value
- ₹429 Cr
- Δ value
- up ₹27.9 Cr
- Status
- Added
- Weight
- 4.14%
- Δ weight
- up 0.22 pts
- Value
- ₹337 Cr
- Δ value
- up ₹46.8 Cr
- Status
- Added
- Weight
- 3.95%
- Δ weight
- up 0.25 pts
- Value
- ₹321 Cr
- Δ value
- up ₹47.5 Cr
- Status
- Added
- Weight
- 3.18%
- Δ weight
- up 0.21 pts
- Value
- ₹259 Cr
- Δ value
- up ₹39.1 Cr
- Status
- Added
- Weight
- 3.17%
- Δ weight
- up 0.24 pts
- Value
- ₹258 Cr
- Δ value
- up ₹40.8 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- down 0.01 pts
- Value
- ₹246 Cr
- Δ value
- up ₹21.7 Cr
- Status
- Added
- Weight
- 3.01%
- Δ weight
- down 0.21 pts
- Value
- ₹245 Cr
- Δ value
- up ₹6.6 Cr
- Status
- Added
- Weight
- 2.94%
- Δ weight
- down 0.26 pts
- Value
- ₹239 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 2.79%
- Δ weight
- down 0.19 pts
- Value
- ₹227 Cr
- Δ value
- up ₹6.6 Cr
- Status
- Added
- Weight
- 2.57%
- Δ weight
- down 0.27 pts
- Value
- ₹209 Cr
- Δ value
- down ₹78 L
- Status
- Held
- Weight
- 2.32%
- Δ weight
- down 0.13 pts
- Value
- ₹189 Cr
- Δ value
- up ₹7.7 Cr
- Status
- Added
- Weight
- 2.24%
- Δ weight
- down 0.35 pts
- Value
- ₹183 Cr
- Δ value
- down ₹9.1 Cr
- Status
- Trimmed
- Weight
- 2.21%
- Δ weight
- up 0.26 pts
- Value
- ₹180 Cr
- Δ value
- up ₹35.7 Cr
- Status
- Added
- Weight
- 1.96%
- Δ weight
- down 0.31 pts
- Value
- ₹160 Cr
- Δ value
- down ₹8.8 Cr
- Status
- Trimmed
- Weight
- 1.87%
- Δ weight
- down 0.15 pts
- Value
- ₹152 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- down 0.06 pts
- Value
- ₹147 Cr
- Δ value
- up ₹8.8 Cr
- Status
- Added
- Weight
- 1.77%
- Δ weight
- up 0.25 pts
- Value
- ₹144 Cr
- Δ value
- up ₹31.8 Cr
- Status
- Added
- Weight
- 1.73%
- Δ weight
- down 0.07 pts
- Value
- ₹141 Cr
- Δ value
- up ₹7.4 Cr
- Status
- Added
- Weight
- 1.61%
- Δ weight
- up 0.02 pts
- Value
- ₹131 Cr
- Δ value
- up ₹13.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.54%
- Δ weight
- up 0.98 pts
- Value
- ₹125 Cr
- Δ value
- up ₹84 Cr
- Status
- Added
- Weight
- 1.12%
- Δ weight
- up 0.04 pts
- Value
- ₹90.9 Cr
- Δ value
- up ₹11 Cr
- Status
- Added
- Weight
- 1.07%
- Δ weight
- down 0.04 pts
- Value
- ₹87.2 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 0.99%
- Δ weight
- down 0.10 pts
- Value
- ₹80.6 Cr
- Δ value
- —
- Status
- Held
- Weight
- 0.75%
- Δ weight
- down 0.06 pts
- Value
- ₹61 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 0.55%
- Δ weight
- up 0.01 pts
- Value
- ₹45.1 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 0.48%
- Δ weight
- up 0.48 pts
- Value
- ₹39.2 Cr
- Δ value
- up ₹39.2 Cr
- Status
- New
- Weight
- 0.39%
- Δ weight
- down 0.07 pts
- Value
- ₹31.8 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 0.30%
- Δ weight
- down 0.01 pts
- Value
- ₹24.5 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
What changed, Jun 2024 to Jul 2024
New New positions (1)
- Emcure Pharmaceuticals Limited0.5% · ₹39.2 Cr
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹130 Cr (+0.38% pts)
- Gland Pharma Limitedup ₹47.5 Cr (+0.25% pts)
- Zydus Lifesciences Limitedup ₹46.8 Cr (+0.22% pts)
- Lupin Limitedup ₹44.4 Cr (−0.15% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2024, the weight rose most in Pharmaceuticals & Biotechnology (+0.5 pts), and fell most in Retailing (−0.2 pts) and Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology78.7% → 79.2%+0.5 pts
- Retailing2.9% → 2.6%−0.2 pts
- Healthcare Services17.6% → 17.4%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2021 | Jul 2023 | Jan 2024 | Apr 2024 | Jun 2024 | Jul 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.1% | 77.3% | 77.4% | 79.0% | 78.7% | 79.2% |
| Healthcare Services | 20.5% | 17.8% | 18.2% | 17.0% | 17.6% | 17.4% |
| Retailing | — | 3.5% | 3.2% | 3.1% | 2.9% | 2.6% |
| Pharmaceuticals | 2.4% | 1.1% | 1.0% | 0.9% | 0.8% | 0.8% |
Allocation in Jul 2024change vs Jun 2024
- Pharmaceuticals & Biotechnology (22)79.2%▲ 0.5 pts
- Healthcare Services (8)17.4%▼ 0.2 pts
- Retailing (1)2.6%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2024
1.5%
▲ 1.0 pts vs Jun 2024
- Cash alone
- 1.6%
- cash and net receivables
- A year earlier
- 2.9%
- Jul 2023 · now ▼ 1.4 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.